Skip to content

The neurophysiological effects of dry needling in patients with upper trapeizus myofascial trigger points

Effect of dry needling on neuromuscular junction response and sympathetic skin response in patients with upper trapeizus myofascial trigger points compared with healthty subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013031612828N1
Enrollment
30
Registered
2013-04-04
Start date
2013-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial trigger point. Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention 1: The sterile acupuncture needles of 0.30 mm diameter and 50 mm long will be used for both groups. The needle will be inserted into the skin over the palpated trigger point and will be
Treatment - Other
The sterile acupuncture needles of 0.30 mm diameter and 50 mm long will be used for both groups. The needle will be inserted into the skin over the palpated trigger point and will be advanced until
The sterile acupuncture needles of 0.30 mm diameter and 50 mm long will be used. The needle will be inserted into the skin over the Trigger Point equivalent of upper terapezius in healthy subjects. Ea

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: subjects with aged between 20 and 40 year old; upper trapezius active Myofascial trigger points (MTrPs). Exclusion criteria: subjects less than 20 years and more than 40 years; subjects with a history of other shoulder or spinal disorders; neck and upper extremity surgery; acute disease; muscle diseases; neurological or systemic disorder (such as lupus erythematus, scleroderma); epilepsy; pregnancy; using sedative drugs; needle phobia; bleeding disorder; anticoagulant medication; previous experience with dry needling for myofascial pain; Skin lesion and infection or inflammatory oedema at MTrPs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Neuromuscular Junction Response (NMJR). Timepoint: before intervention and immediately after intervention. Method of measurement: Electrodignostic technique of repeatitive nerve stimulation (RNS) in trapezius muscle.;Sympathetic Skin Response (SSR). Timepoint: before intervention and immediately after intervention. Method of measurement: stimulus over the median nerve at the wrist and records on the palm of the hand.

Secondary

MeasureTime frame
Pain Intensity. Timepoint: before intervention and immediately after intervention. Method of measurement: Pain intensity will be self rated by subjects on a 0-10 numerical rating scale with 0 representing no pain and 10 representing the worst imaginable pain.;Pressure Pain Threshold. Timepoint: before intervention and immediately after intervention. Method of measurement: ; by use a pressure algometer According to Kilogram per square centimeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Abbaszadeh-Amirdehi

Tehran University of Medical Sciences

abbaszadeh_m@razi.tums.ac.irmaryam_abbasszadeh@yahoo.com+98 21 2222 8052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026